Showing 6601-6610 of 7755 results for "".
- DERM2019 Day 4: Contact Dermatitis, Dermoscopy Bootcamp, and Morehttps://practicaldermatology.com/news/derm2019-day-4-contact-dermatitis-dermoscopy-bootcamp-and-more/2460103/The last day of DERM2019 included a dermoscopy session and several other key presentations from Jennifer Stein, David Cohen, and Gilly Munavalli. Here’s a brief recap from some of those talks! Dermoscopy Bootcamp Presented by Jennifer Stein
- RealSelf Releases 2019 Sun Safety Reporthttps://practicaldermatology.com/news/realself-releases-2019-sun-safety-report/2460102/According to the 2019 RealSelf Sun Safety Report, only 1 in 10 adults in the US uses sunscreen every day, and almost half (47 percent) of Americans never wear sunscreen, and women are significantly more likely than men to wear sunscreen on
- Baylor Dermatologist Offers Anti-Aging Advice in Response to FaceApp Crazehttps://practicaldermatology.com/news/baylor-dermatologist-offers-anti-aging-advice-in-response-to-faceapp-craze/2460097/The FaceApp is taking social media by storm as celebrities and social media users across the nation morph their faces to look decades older. While it is currently being used for comedic purposes, you may have patients asking how to keep the app from turning into reality. Rajani Katta, M
- Revance Adds New Member to Board of Directorshttps://practicaldermatology.com/news/revance-adds-new-member-to-board-of-directors/2460096/Chris Nolet is the newest member of Revance Therapeutics, Inc.’s Board of Directors. He will serve as the Chair of the Revance Audit Committee. “Chris Nolet brings an extraordinary record of industry-shaping consultation to the Revance Bo
- AAD Honors Chicago Doctors for Multidisciplinary Approach to Eczema Carehttps://practicaldermatology.com/news/aad-honors-chicago-doctors-for-multidisciplinary-approach-to-eczema-care/2460094/Dermatologist Jonathan Silverberg, MD, PhD, MPH, FAAD, and sleep neurologist Hrayr Attarian, MD, were named Patient Care Heroes by the American Academy of Dermatology for teaming up to provide coordinated, multidisciplinary care to patients with eczema. Both physicians practice medicine
- Positive Results Seen in Phase 3 FMX101 Acne Studyhttps://practicaldermatology.com/news/study-positive-results-see-in-phase-3-fmx101-acne-study/2460088/In patients with moderate to severe acne vulgaris, treatment with FMX101 4% topical minocycline foam is well tolerated and effective for reducing the number of inflammatory lesions, according to results of a randomized trial published in the Journal of the American Academy of Dermatology
- LEO Pharma Completes Acquisition of Bayer’s Prescription Dermatology Businesshttps://practicaldermatology.com/news/leo-pharma-completes-acquisition-of-bayers-prescription-dermatology-business/2460086/LEO Pharma and Bayer announced the achievement of the relevant closing conditions to allow the transfer of Bayer’s global prescription dermatology business to LEO Pharma. The companies first announced the proposed transaction on July 31, 2018 and completed the first step of the acquisition
- SENTÉ Names Adelle Walker as Chief Marketing Officerhttps://practicaldermatology.com/news/sente-names-adelle-walker-as-chief-marketing-officer/2460080/SENTÉ® has appointed Adelle Walker Chief Marketing Officer. As Chief Marketing Officer (CMO), she will take an executive leadership role in defining pipeline strategy along with internal and external portfolio planning. Her commercialization leadership will span across all fa
- Duobrii Lotion for Plaque Psoriasis Hits Shelveshttps://practicaldermatology.com/news/duobrii-lotion-for-plaque-psoriasis-hits-shelves/2460079/Ortho Dermatologics’ Duobrii (halobetasol propionate and tazarotene) Lotion, 0.01%/0.045%, is now available. Approved by the U.S. Food and Drug Administration on April 25, 2019, Duobrii is the first and only topical lotion that contains a uniq
- AbbVie to Acquire Allerganhttps://practicaldermatology.com/news/abbvie-to-acquire-allergan/2460076/AbbVie Inc. and Allergan plc have entered into a definitive transaction agreement under which AbbVie will acquire Al